.png)
Of course, a sound idea still requires solid execution. So why are we confident in our approach?
OUR INVESTORS
First, we’d point to our investors include Lightspeed, Nexus, Y Combinator, and General Catalyst, firms with a track record of expertise in AI and digital health.
OUR PARTNERS
Second, we’d point to our leadership in creating a consortium of over 20 NCI-designated cancer centers, along with Ci4CC. The group, named the Collaboration for Oncology focused LLM Training (COLT), recognizes that generative AI is a nascent technology and oncology is a zero-fail space. We therefore partner together to share best practices, and determine performance benchmarks and safety standards.
We recognize that generative AI is a new technology and any model, no matter how well designed, will have limitations. We also recognize the life-and-death consequences of oncology research and care. Accordingly, we strive to be:
01
True Collaboration
Success in healthcare AI often requires collaborative efforts. We foster teamwork not only within our company but also with our partner providers, integrating their insights to continually refine and enhance our AI and software. Together, we create solutions that are more than the sum of their parts.
02
Constant Support
We provide continuous support and tailored learning opportunities for our end users to ensure they can best utilize our solutions. Our goal is to empower healthcare professionals with advanced tools needed for optimal patient care and innovative research.
03
Pioneer Responsibly
In the critical field of oncology, we hold ourselves to the highest standards of ethical innovation. Our work is provider- and patient-centric, ensuring that our advancements in healthcare AI are developed responsibly, with a commitment to doing no harm and prioritizing safety above all.
04
Drive Meaningful Impact
Our focus is on creating a significant positive impact in the lives of cancer patients and the healthcare teams who care for them. We measure success by the real-world utility and effectiveness of our solutions, aiming to transform oncology care through technology.
